Filter posts

Life Science Leader Asks: What Biopharma Trends Should Pharma Execs Be Paying Attention To?

In my last installment of this four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas & …

The International Space Station Brings Big Buzz and Big Science to BIO 2015

This year, the BIO International Convention will raise the bar, yet again, through a collaborative …

Life Science Leader Asks: What Areas Are Often Overlooked by Academics Turned Biotech Entrepreneurs?

In my third installment of a four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

5 Days Until BIO 2015: Meet the Official Bloggers!

The 2015 BIO International Convention brings together biotech leaders, innovators and companies from across the …

MIT Hacking Medicine Presents Idea Design Studio at #BIO2015

Have you ever wanted to improve your healthcare experience? Have you ever felt like you …

The Convergence of BioPharma and Digital Medicine

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing …

From BioGENEius to Champion of Biotech

After losing a friend to cancer at a young age, I knew that I would …

10 Days Until BIO 2015: Official Bloggers Preview

Next week, we will be introducing you to BIO’s Official Bloggers, writers who are on …

Life Science Leader Asks: Are you Ready for a Grant-Funding QA Audit?

In my second installment of a four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas …